Research Article

Seroprevalence of Hepatitis B Surface Antigen amongst Patients in Selected Hospitals in Kaduna Metropolis, Nigeria

Yaki, L. M1*, Idam S. B.2, Chock, J.J3
1 Department of Microbiology, Faculty of Science, Kaduna State University, Kaduna
2 Department of Microbiology, Faculty of Science, Kaduna State University, Kaduna, Nigeria
3 Department of Medical Microbiology, College of Medical Sciences, Kaduna State University, Kaduna, Nigeria
* Corresponding author: lucyyaki@gmail.com
Published: Dec, 2020
DOI: 10.67614/njm.2020.px9f2lk5
Pages: 5269-5278

Abstract

Hepatitis B virus (HBV) infection has been identified as one of the most common infectious  diseases of major health concern globally. The common method for detecting hepatitis B infection is to  detect the presence of hepatitis B surface antigen (HBsAg).This research work was undertaken to  determine the seroprevalence and possible risk factors of hepatitis B surface antigen amongst patients in  selected hospitals in Kaduna metropolis, Kaduna State, Nigeria. Two hundred (200) blood samples were  collected from patients who presented themselves for HBV screening and tests were carried out for one  hepatitis B virus serological marker: HBsAg using Agary HBsAg test kits. Information was obtained for  risk factors using structured questionnaire. There was an increased number of females (55.5%) compared  to males (44.5%) recruited for this study. An overall seroprevalence of 9.5% for HBV infection was  obtained from this study. About 5.4% and 14.6%of the female and male patients respectively were HBsAg  positive. There was significant association between patients with hepatitis B family history ( ᵪ 2  =25.319;p=0.001), intravenous drug use (ᵪ2=7.707;p=0.006), tribal marks/ tattoos (ᵪ2 =3.879;p=0.049) and  traditional barbers (ᵪ2 =12.604;p=0.001). Other risk factors studied were not significantly associated with  HBsAg seropositivity. The highest and lowest frequency of HBsAg infection was observed in age group;  35-44 years (19.2%) and 15-24 years (5.3%) respectively. The high occurrence of HBsAg in this study  calls for an urgent intervention strategy that place emphasizes on the need for enlightenment and massive  vaccination against HBV

Keywords

Hepatitis B virus HBsAg Risk factors Seroprevalence

References

  1. Ado, A., Alhassan, S., Chonoko, U.G. and Samaila, A.U. (2010). Seroprevalence of Hepatitis B surface Antigen (HBsAg) among Blood Donors Attending Ahmadu Bello University Teaching Hospital (ABUTH) Zaria, Nigeria. Bayero Journal of Pure and Applied Sciences. 3(1):20-22.
  2. Araoye, M.O. (2003). Research Methodology with Statistics for Health and Social Sciences. Nathadex Publishers, Ilorin.
  3. Edie-Aszuke, U.A., Abubakar, Z, Asuke, S. (2015). Seroprevalence of Hepatitis B Infection among Outpatient attending a Public Tertiary Hospital in Kaduna State in Nigeria. A Journal of Topical Medicine and Surgery.3(3): 189.
  4. Erena, A.N. & Tefera, T.B. (2014). Prevalence of hepatitis B surface antigen (HBsAg) and its risk factors among individuals visiting Goba General Hospital, South East Ethiopia, 2. BMC Research Notes 7: 833-838.
  5. Eustace, B.B., Adenike, A.R., Bala, M.A., Shukurat, B.B., Mustapha, A., Musili, O.R., Banke, O.M &Abdulateef, L. (2019). Prevalence of Hepatitis B virus in Nigeria: Review update. Annals of Public Health and Epidemiology 1(1): 1-7
  6. Georing, R.V., Dockrell, H.M., Zukerman, M., Roitt, I.M and Chiodini, P.L. Mims Medical Microbiology. Fifth edition, pp. 293-300.
  7. Google Inc... (2016). In Encyclopedia Britannica. Retrieved from http://academic.eb.com/levels/collegiate/article/471099
  8. Itodo, S.E.,Otu-Bassey, I.B. and Cecil K.D (2016).Prevalence of Hepatitis B Surface Antigen and Hepatitis C Antibody in Abuja Municipal Area Council FCT-Nigeria the North-Central Geopolitical Zone. Journal of Hepatitis Research. 3(1):1034.
  9. Isa, I, M, Abdullahi, S.A., Sani, M.A and Esona, M.D. (2015). Seroprevalence of Hepatitis B Virus in a Tertiary Institution in North Western Nigeria. African Journal of Microbiology Research. 9(3):171-179, 21.
  10. MacLachlan, J.H. & Cowie, B.C. (2015). Hepatitis B virus Epidemiology. Cold Spring Harbor Perspective in Medicine 5:21410
  11. Makuza, J.D., Rwema, J.O.T., Ntihabose, C.K., Dushimiyimana, D., Umutesi, J., Nisingizwe, M.P., Serumondo, J., Semakula, M., Riedel, D.J & Nsanzimana, S. (2019). Prevalence of hepatitis B surface antigen (HBsAg) positivity and its associated factors in Rwanda. BMC Infectious Disease19: 381-390.
  12. Monica, Cheesbrough (2006). District Laboratory practical in tropical countries. Cambridge University Press, Edinburg building, Trumoington street, Cambridge CB2 1IR, United Kingdom.
  13. Musa, B.M., Bussell, S., Borodo, M.M., Samaila, A.A and Femi, O.L. (2015). Prevalence of Hepatitis B Virus Infection in Nigeria, 2000-2013: A systematic review and Meta-analysis. Nigerian Journal of Clinical Practice. 18(2):163-172.
  14. Ndako, J.A., Nwankiti, O.O., Echeonwu, G.O.N., Junaid, S.A., Anaele, O. &Anthony, T.J., (2011). Studies of Prevalence and Risk factors for Hepatitis B surface Antigen among secondary school students in North-Central, Nigeria. Sierra Leone Journal of BiomedicalResearch 3 (3): 163-168.
  15. Ndako, A.J., Nwankiti, O.O., Kwari, B.E., Echeonwu, B.C., Adekeye, M.A., Agbontale, J., Gyang, J., Uzoechina, R.A., Akwaowo, E., Olawuyi, N. and Dalpay, A.K. (2012). Serological Evidence of Hepatitis B surface Antigen (HBsAg) among Nigeria Youths. Nigeria Health/AIDs indicator and Impact Survey (NAIIS) report 2020. https://www.naiis.ng/1
  16. Pennap, G.R. Nwachukwu, O., Ishaleku, D. & Ombagalu, R.J. (2011). Hepatitis B virus carriage among students of a Nigeria Tertiary Institution: A cohort of eligible blood donors. ResearchJournal of Medical Sciences 5 (2): 90-93.
  17. Sadoh, A.E. and Sadoh, W.E. (2014). Does Nigeria need the Birth Dose of the Hepatitis B Vaccine? Nigerian Journal of Paediatrics. 41(2): 104 – 109.
  18. Waje, T., Muhammad, Y., Dadah, A. and Maikaje, D.B. (2016). A Comparative study on Hepatitis B Surface Antigen Seroprevalence between Outpatients in Public and Private Hospitals within Kaduna Metropolis, Nigeria. American Journal of Epidemiology and Infectious Diseases. 4(4): 47- 63.
  19. World Health Organization. (2016). Where Hepatitis B is a problem globally.pp.1-2 retrieved from http://who.int/cdr/disease/../en/index1.html
How to Cite

M, Y. L., B., I. S., & J.J, C. (2020). Seroprevalence of Hepatitis B Surface Antigen amongst Patients in Selected Hospitals in Kaduna Metropolis, Nigeria. Nigerian Journal of Microbiology, 34(2), 5269-5278. https://doi.org/10.67614/njm.2020.px9f2lk5

Y. L. M, I. S. B., and C. J.J, "Seroprevalence of Hepatitis B Surface Antigen amongst Patients in Selected Hospitals in Kaduna Metropolis, Nigeria," Nigerian Journal of Microbiology, vol. 34, no. 2, pp. 5269-5278, December 2020. doi: 10.67614/njm.2020.px9f2lk5

Share this article:
Facebook X / Twitter LinkedIn
Download PDF View Full Text (PDF) Back to Articles